|
UBA5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.61059999956603E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.82760000045602E-07 |
| Normal-vs-Stage2 |
3.283700E-02 |
| Normal-vs-Stage3 |
8.12000000016688E-07 |
| Normal-vs-Stage4 |
6.05379968376951E-10 |
| Stage1-vs-Stage2 |
8.465600E-01 |
| Stage1-vs-Stage3 |
6.137500E-02 |
| Stage1-vs-Stage4 |
8.396000E-04 |
| Stage2-vs-Stage3 |
1.305620E-01 |
| Stage2-vs-Stage4 |
8.177600E-03 |
| Stage3-vs-Stage4 |
1.485790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.81629999995714E-06 |
| Normal-vs-AfricanAmerican |
3.839800E-04 |
| Normal-vs-Asian |
1.199510E-04 |
| Caucasian-vs-AfricanAmerican |
9.162600E-01 |
| Caucasian-vs-Asian |
3.522800E-01 |
| AfricanAmerican-vs-Asian |
3.594000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.21509999950753E-07 |
| Normal-vs-Female |
8.202800E-03 |
| Male-vs-Female |
1.443840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.576400E-03 |
| Normal-vs-Extreme_Weight |
5.70499999463792E-08 |
| Normal-vs-Obese |
3.979100E-04 |
| Normal-vs-Extreme_Obese |
5.335800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.628600E-01 |
| Normal_Weight-vs-Obese |
7.327400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.801600E-01 |
| Extreme_Weight-vs-Obese |
2.252800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.024200E-01 |
| Obese-vs-Extreme_Obese |
6.424200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.47909999999685E-05 |
| Normal-vs-Age(41-60Yrs) |
2.815500E-04 |
| Normal-vs-Age(61-80Yrs) |
4.11909999997739E-06 |
| Normal-vs-Age(81-100Yrs) |
1.19470000004007E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.979220E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.345000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.704380E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.948600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.024900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.596000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.625600E-04 |
| Normal-VS-Type2 PRCC |
1.61350000027483E-07 |
| Normal-VS-KIRP CIMP |
4.01620000034519E-07 |
| Normal-VS-Unclassified PRCC |
5.202800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.395900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.793600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.098180E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.351000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.527400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.415600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.0692999999895E-06 |
| Normal-vs-N1 |
8.48340000025871E-07 |
| Normal-vs-N2 |
2.65129999998948E-06 |
| N0-vs-N1 |
4.223400E-01 |
| N0-vs-N2 |
1.416150E-01 |
| N1-vs-N2 |
1.894650E-01 |
|
|
